U.S. market Closed. Opens in 10 hours 1 minute

MIRM | Mirum Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue186.37M77.06M19.14MN/AN/A
Cost of Revenue47.37M12.37M1.90M623.00K324.00K
Gross Profit139.01M64.69M17.23M-623.00K-324.00K
Operating Expenses248.16M195.91M190.65M104.30M54.74M
Selling, General & Admin145.88M89.07M59.22M22.69M11.75M
Research & Development102.28M106.84M131.43M81.61M42.99M
Other Operating Expenses-2.82M365.00K107.42M-192.00K-21.00K
Operating Income-109.15M-131.22M-173.41M-104.30M-54.74M
Other Expenses / Income-53.27M-10.85M89.46M1.03M2.21M
Before Tax Income-162.42M-142.07M-83.95M-103.26M-52.53M
Income Tax Expenses991.00K-6.41M37.00K6.00K21.00K
Net Income-163.41M-135.66M-83.99M-103.27M-52.55M
Interest Expenses15.11M15.98M17.59M335.00KN/A
Basic Shares Outstanding40.89M33.84M30.32M25.25M22.99M
Diluted Shares Outstanding40.89M33.84M30.32M25.25M22.99M
EBITDA-98.33M-127.00M-64.65M-102.93M-54.74M
EBITDA Margin-52.76%-164.80%-337.83%0.00%0.00%
EBIT-147.32M-126.09M-66.36M-102.93M-52.53M
EBIT Margin-79.04%-163.62%-346.75%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙